{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:27:32Z","timestamp":1772062052320,"version":"3.50.1"},"reference-count":24,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T00:00:00Z","timestamp":1678492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Introduction: COVID-19 infection is often associated with a vast spectrum of opportunistic bacterial and fungal infections. Herein, we share a summary of the first case of COVID-19-associated mucormycosis (CAM) in a patient from Romania. Case presentation: A 51-year-old male non-smoker, with no known relevant medical history, who denied any previous alcohol use and was vaccinated against COVID-19 (complete scheme with Vaxzevria), was admitted to the hospital for severe COVID-19 infection. The first mucormycosis-related symptoms were reported on the eighth day of admission and were followed by the rapid deterioration of the patient\u2019s condition and, consequently, death. The main aggravating factors, which were identified to be associated with the development of mucormycosis and with the poor outcome, were the association of severe COVID-19, new-onset COVID-19-triggered type 2 diabetes, and corticoid treatment for severe COVID-19. Conclusion: The association between severe COVID-19 and newly diagnosed type 2 diabetes, triggered by COVID-19 infection, increases the risk of severe opportunistic fungal infections and the associated mortality rates.<\/jats:p>","DOI":"10.3390\/medicina59030555","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T05:36:21Z","timestamp":1678685781000},"page":"555","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mucormycosis in a Patient with Severe COVID-19 Disease\u2014The First Case Report in Romania and a Literature Review"],"prefix":"10.3390","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9240-922X","authenticated-orcid":false,"given":"Beatrice","family":"Mahler","sequence":"first","affiliation":[{"name":"National Institute of Pneumology Marius Nasta, 050159 Bucharest, Romania"},{"name":"Pneumology Department, University of Medicine and Pharmacy Carol Davila, 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana Andreea","family":"Parliteanu","sequence":"additional","affiliation":[{"name":"National Institute of Pneumology Marius Nasta, 050159 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavian","family":"Alexe","sequence":"additional","affiliation":[{"name":"Diabetes Department, Dunarea de Jos University, 800008 Galati, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8516-4674","authenticated-orcid":false,"given":"Corina","family":"R\u00ee\u0219c\u0103 Popazu","sequence":"additional","affiliation":[{"name":"Diabetes Department, Dunarea de Jos University, 800008 Galati, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina Elena","family":"Ene","sequence":"additional","affiliation":[{"name":"National Institute of Pneumology Marius Nasta, 050159 Bucharest, Romania"},{"name":"Pneumology Department, University of Medicine and Pharmacy Carol Davila, 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan","family":"Timar","sequence":"additional","affiliation":[{"name":"Diabetes Department, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania"},{"name":"Pius Brinzeu Emergency Hospital, 300723 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tudor","family":"Constantinescu","sequence":"additional","affiliation":[{"name":"National Institute of Pneumology Marius Nasta, 050159 Bucharest, Romania"},{"name":"Pneumology Department, University of Medicine and Pharmacy Carol Davila, 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,11]]},"reference":[{"key":"ref_1","unstructured":"Kubin, C.J., McConville, T.H., and Dietz, D. (2021). Open Forum Infectious Diseases, Oxford University Press."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12281-019-0337-1","article-title":"Mucormycosis: Pathogenesis and Pathology","volume":"13","author":"Challa","year":"2019","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_3","unstructured":"(2021, February 25). Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Diseases (DFWED), Available online: https:\/\/www.cdc.gov\/fungal\/diseases\/mucormycosis\/index.html."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India-Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India","volume":"27","author":"Patel","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_7","first-page":"100057","article-title":"Mucormycosis in COVID-19 pandemic: Risk factors and linkages","volume":"2","author":"Kumar","year":"2021","journal-title":"Curr. Res. Microb. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"102196","DOI":"10.1016\/j.dsx.2021.102196","article-title":"Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India","volume":"15","author":"Mishra","year":"2021","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.cmet.2021.05.015","article-title":"SARS-CoV-2 infection induces beta cell transdifferentiation","volume":"33","author":"Tang","year":"2021","journal-title":"Cell Metab."},{"key":"ref_10","unstructured":"(2022, November 17). Available online: https:\/\/directorsblog.nih.gov\/2021\/06\/08\/how-covid-19-can-lead-to-diabetes\/."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"The RECOVERY Collaborative Group (2021). Dexamethasone in hospitalized patients with COVID-19. N. Engl. J. Med., 384, 693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref_12","unstructured":"(2022, November 17). Available online: https:\/\/msmps.gov.md\/legislatie\/covid-19\/protocoale-si-ghiduri-covid-19\/."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1182\/blood-2011-03-316430","article-title":"How I treat mucormycosis","volume":"118","author":"Kontoyiannis","year":"2011","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ponnaiah, M., Ganesan, S., Bhatnagar, T., Thulasingam, M., Majella, M.G., Karuppiah, M., Rizwan, S.A., Alexander, A., Sarkar, S., and Kar, S.S. (2022). Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0272042"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/myc.13391","article-title":"Serum iron indices in COVID-19-associated mucormycosis: A case-control study","volume":"65","author":"Kumar","year":"2022","journal-title":"Mycoses"},{"key":"ref_16","unstructured":"(2022, November 18). Available online: https:\/\/www.infectiousdiseaseadvisor.com\/home\/decision-support-in-medicine\/infectious-diseases\/agents-of-mucormycosis-microbiology\/."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11046-021-00584-8","article-title":"Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World","volume":"186","author":"Muthu","year":"2021","journal-title":"Mycopathologia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: The French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/myc.13379","article-title":"Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals","volume":"65","author":"Seidel","year":"2022","journal-title":"Mycoses"},{"key":"ref_20","unstructured":"(2022, November 18). Available online: https:\/\/www.who.int\/india\/emergencies\/coronavirus-disease-(covid-19)\/mucormycosis."},{"key":"ref_21","unstructured":"(2022, November 19). Available online: https:\/\/en.wikipedia.org\/wiki\/Mucormycosis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Guemas, E., Cassaing, S., Malavaud, S., Fillaux, J., Chauvin, P., Leli\u00e8vre, L., Ruiz, S., Riu, B., Berry, A., and Iriart, X. (2022). A Clustered Case Series of Mucorales Detection in Respiratory Samples from COVID-19 Patients in Intensive Care, France, August to September 2021. J. Fungi, 8.","DOI":"10.3390\/jof8030258"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jhin.2022.01.016","article-title":"Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India\u2014A multi-centre study","volume":"122","author":"Biswal","year":"2022","journal-title":"J. Hosp. Infect."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"953750","DOI":"10.3389\/fcimb.2022.953750","article-title":"Evaluation of environmental Mucorales contamination in and around the residence of COVID-19-associated mucormycosis patients","volume":"12","author":"Ghosh","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/3\/555\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:52:44Z","timestamp":1760122364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/3\/555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,11]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["medicina59030555"],"URL":"https:\/\/doi.org\/10.3390\/medicina59030555","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,11]]}}}